THE INFLUENCE OF HEPATIC-ARTERY LIGATION AND OF VASOPRESSIN ON LIVER-TUMOR BLOOD-FLOW IN RATS

被引:10
作者
NAREDI, P
LINDNER, P
HOLMBERG, SB
SODERBERG, R
CARLSSON, G
GUSTAVSSON, B
JACOBSSON, L
HAFSTROM, L
机构
[1] GOTHENBURG UNIV,SAHLGRENSKA HOSP,DEPT SURG,S-41345 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,SAHLGRENSKA HOSP,DEPT RADIAT PHYS,S-41345 GOTHENBURG,SWEDEN
[3] EASTERN HOSP,DEPT SURG,GOTHENBURG,SWEDEN
关键词
HEPATIC ARTERY OCCLUSION; XE-133-WASHOUT; VASOPRESSIN; LIVER TUMOR;
D O I
10.1002/jso.2930500203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The blood flow in an experimental adenocarcinoma in the rat liver was determined with the Xe-133-washout technique before and after hepatic artery ligation (HAL). There was an initial reduction of the washout of 50%. This was further reduced after 1 day by 50%, which was maintained for 7 days. Seven days after HAL or sham procedures the Xe-133-washout was of similar magnitude in the liver tumours, although after the sham procedure the tumours were larger (3.4 g vs. 1.5 g). The estimated tumour blood flow was then approximately 0.04 ml x min-1 x g-1. The influence on normal liver parenchyma of HAL was a reduction at 30 minutes, which was maintained for 7 days. Postacton(R)-a synthetic vasopressin-did not influence the Xe-133-washout in normal liver parenchyma in non-tumour, as well as in tumour-bearing animals. There was no influence of Postacton(R) on the Xe-133-washout in the liver tumours. Thirty minutes after HAL Postacton(R) gave a reduction of blood flow in normal liver parenchyma of tumour-bearing animals, which is thus only from the portal vein. In tumours Postacton(R) did not significantly reduce the tumour blood flow immediately after HAL.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 41 条
[1]  
ACKERMAN NB, 1972, CANCER, V29, P435, DOI 10.1002/1097-0142(197202)29:2<435::AID-CNCR2820290227>3.0.CO
[2]  
2-K
[3]  
ACKERMAN NB, 1974, SURGERY, V75, P589
[4]  
ACKERMAN NB, 1969, SURGERY, V66, P1067
[5]  
ACKERMAN NB, 1986, CANCER, V58, P1653, DOI 10.1002/1097-0142(19861015)58:8<1653::AID-CNCR2820580813>3.0.CO
[6]  
2-P
[7]  
ACKERMAN NB, 1984, MICROCIRC ENDOTH LYM, V1, P547
[8]  
Allen N, 1975, Trans Am Neurol Assoc, V100, P157
[9]  
ALMERSJO O, 1976, ACTA CHIR SCAND, V142, P131
[10]   RELATIONSHIP BETWEEN HEMATOCRIT AND SOLUBILITY OF 133XE IN BLOOD [J].
ANDERSEN, AM ;
LADEFOGED, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (11) :1684-+